Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $5.0 million.

  • Immunome's Non-cash Items rose 7677.66% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 7677.66%. This contributed to the annual value of $75.2 million for FY2024, which is 228593.9% up from last year.
  • According to the latest figures from Q3 2025, Immunome's Non-cash Items is $5.0 million, which was up 7677.66% from $62.9 million recorded in Q2 2025.
  • Immunome's 5-year Non-cash Items high stood at $146.2 million for Q1 2024, and its period low was $1.4 million during Q1 2023.
  • For the 3-year period, Immunome's Non-cash Items averaged around $31.7 million, with its median value being $3.6 million (2025).
  • As far as peak fluctuations go, Immunome's Non-cash Items skyrocketed by 1058270.1% in 2024, and later plummeted by 9756.2% in 2025.
  • Immunome's Non-cash Items (Quarter) stood at $45.4 million in 2023, then skyrocketed by 65.78% to $75.2 million in 2024, then plummeted by 93.39% to $5.0 million in 2025.
  • Its Non-cash Items stands at $5.0 million for Q3 2025, versus $62.9 million for Q2 2025 and $3.6 million for Q1 2025.